Katherine Freeman

Katherine Freeman

Auto-generated profile, based on publicly available information

Katherine Freeman

Florida Atlantic University, Division of Research Boca Raton Florida USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2021 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GSGERALYN SCHULZ
GERALYN SCHULZ
AHAngela Halpern
Angela Halpern
JSJennifer Spielman
Jennifer Spielman
LRLorraine Ramig
Lorraine Ramig
IPIra Panzer
Ira Panzer
KFKatherine Freeman
Katherine Freeman
The majority of people with Parkinson’s disease (PD) experience both prosodic changes (reduced vocal volume, reduced pitch range) and articulatory changes (imprecise articulation) that often limit speech intelligibility and may contribute to significant declines in quality of life. We conducted a randomized control trial comparing two intensive treatments, voice (LSVT LOUD) or articulation (LSVT ARTIC) to assess single word intelligibility in the presence of background noise (babble and mall). Participants (64 PD and 20 Healthy) read words from the diagnostic rhyme test (DRT), an ANSI Standard for measuring intelligibility of speech, before and after one month (treatment or no treatment). Teams of trained listeners blindly rated the data. Speech intelligibility of words in the presence of both noise conditions improved in PD participants who had LSVT LOUD compared to the groups that had LSVT ARTIC or no treatment. Intensive speech treatment targeting prominent prosodic variables in LSVT LOUD had a positive effect on speech intelligibility at the single word level in PD.

8 November 2014 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
RBReginald C. W. Bell
Reginald C. W. Bell
AKAshwin A. Kurian
Ashwin A. Kurian
KFKatherine D. Freeman
Katherine D. Freeman

18 January 2011 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
RGRobyn D. Gartner
Robyn D. Gartner
TLTerry L. Levin
Terry L. Levin
SBSteven H. Borenstein
Steven H. Borenstein
BHBokyung Kim Han
Bokyung Kim Han
EBEinat Blumfield
Einat Blumfield
KFKatherine Freeman
Katherine Freeman

8 June 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
TJTarsha Jones
Tarsha Jones
AGAshlee Guzman
Ashlee Guzman
TSThomas Silverman
Thomas Silverman
KFKatherine Freeman
Katherine Freeman
RKRita Kukafka
Rita Kukafka
KCKatherine Crew
Katherine Crew
Background: Chemopreventive agents such as selective estrogen receptor modulators and aromatase inhibitors have proven efficacy in reducing breast cancer risk by 41% to 79% in high-risk women. Women at high risk of developing breast cancer face the complex decision of whether to take selective estrogen receptor modulators or aromatase inhibitors for breast cancer chemoprevention. RealRisks is a patient-centered, web-based decision aid (DA) designed to promote the understanding of breast cancer risk and to engage diverse women in planning a preference-sensitive course of decision making about taking chemoprevention. Objective: This study aims to understand the perceptions of women at high risk of developing breast cancer regarding their experience with using RealRisks—a DA designed to promote the uptake of breast cancer chemoprevention—and to understand their information needs. Methods: We completed enrollment to a randomized controlled trial among 300 racially and ethnically diverse women at high risk of breast cancer who were assigned to standard educational materials alone or such materials in combination with RealRisks. We conducted semistructured interviews with a subset of 21 high-risk women enrolled in the intervention arm of the randomized controlled trial who initially accessed the tool (on average, 1 year earlier) to understand how they interacted with the tool. All interviews were audio recorded, transcribed verbatim, and compared with digital audio recordings to ensure the accuracy of the content. We used content analysis to generate themes. Results: The mean age of the 21 participants was 58.5 (SD 10.1) years. The participants were 5% (1/21) Asian, 24% (5/21) Black or African American, and 71% (15/21) White; 10% (2/21) of participants were Hispanic or Latina. All participants reported using RealRisks after being granted access to the DA. In total, 4 overarching themes emerged from the qualitative analyses: the acceptability of the intervention, specifically endorsed elements of the DA, recommendations for improvements, and information needs. All women found RealRisks to be acceptable and considered it to be helpful (21/21, 100%). Most women (13/21, 62%) reported that RealRisks was easy to navigate, user-friendly, and easily accessible on the web. The majority of women (18/21, 86%) felt that RealRisks improved their knowledge about breast cancer risk and chemoprevention options and that RealRisks informed their (17/21, 81%) decision about whether or not to take chemoprevention. Some women (9/21, 43%) shared recommendations for improvements, as they wanted more tailoring based on user characteristics, felt that the DA was targeting a narrow population of Hispanic or Latina by using graphic novel–style narratives, wanted more understandable terminology, and felt that the tool placed a strong emphasis on chemoprevention drugs. Conclusions: This qualitative study demonstrated the acceptability of the RealRisks web-based DA among a diverse group of high-risk women, who provided some recommendations for improvement.

13 October 2011 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
KFKanwal M. Farooqi
Kanwal M. Farooqi
SCScott R. Ceresnak
Scott R. Ceresnak
KFKatherine Freeman
Katherine Freeman
RPRobert H. Pass
Robert H. Pass

14 November 2024 in Journal of Transport & Health
Verified
Journal Article
Open access
LMLouis A. Merlin
Louis A. Merlin
DSDavid A. Simpson
David A. Simpson
KFKatherine Freeman
Katherine Freeman
SHSerena Hoermann
Serena Hoermann
JRJohn Renne
John Renne